BronwenEShawMD

PubMed

• 27 citations
  Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation
  Maxim Norkin, Bronwen E. Shaw, Ruta Brazauskas, Heather R. Tecca, Helen Leather
  Biology of Blood and Marrow Transplantation. 2019-02-01
• 89 citations
  National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
  Bronwen E. Shaw, Antonio Jimenez-Jimenez, Linda J. Burns, Brent R. Logan, Farhad Khimani
  Journal of Clinical Oncology. 2021-04-27
• 3 citations
  Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for Intern...
  Rachel Cusatis, Carlos Litovich, Zhongyu Feng, Mariam Allbee-Johnson, Miranda Kapfhammer
  Transplantation and Cellular Therapy. 2024-09-01

Journal Articles

• Current Use of Biosimilar G-CSF for Haematopoietic Stem Cell Mobilisation  
  Bronwen Shaw, MD, Nature
• Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors  
  Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
• Motives for Joining an Unrelated HSC Donor Registry: Description, Categorization, and Association with Donor Availability  
  Bronwen Shaw, MD, Nature
• Patient-Reported Outcomes and Health Status Associated with Chronic Graft-Versus-Host Disease  
  Bronwen Shaw, MD, Haematologica
• Join now to see all

Abstracts/Posters

• Building a National CML Registry
  Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the...
  Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor (CAR)-T Cell Therapy
  Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Lower Hematopoietic Progenitor Cell Counts and Yields at Subsequent Donations Is Influenced By a Shorter Inter-Donation Interval between the First and Subsequent Mobil...
  Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Risk Factors for the Development of Cutaneous Melanoma after Allogeneic Hematopoietic Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Impact of Myeloablative Total Body Irradiation Versus Chemotherapy on Late Effects and Survival Among Adolescent and Young Adult Survivors of Hematopoietic Cell Transp... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018